Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2000
05/23/2000US6066465 Measuring concentration of cyclophilins in blood sample, comparing to control, and evaluating degree of shock by increase of cytophilin concentration over control levels
05/23/2000US6066463 Method and compositions for treatment of BCR-ABL associated leukemias and other cell proliferative disorders
05/23/2000US6066340 Process for the preparation of microspheres containing biologically active components
05/23/2000US6066338 Method of using lectins for contraception
05/23/2000US6066324 Carboxyl terminal of papilloma virus L1 region is not required for formation of virus-like particles
05/23/2000US6066323 Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
05/23/2000US6066322 Administering antibody to treat asthma; treating helper t-cell mediated conditions
05/23/2000US6066321 Diagnosing inflammation and autoimmune diseases
05/23/2000US6066320 Isolating antiserum with nerve cells presenting anti-prion protein
05/23/2000US6066319 Administering membrane attack complex (mac) transmembrane channel forming agent which is an antibody simultaneously therewith an effective amount of a therapeutic or diagnostic agent
05/23/2000US6066318 Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors
05/23/2000US6066317 Method of using IL-11 for treating deficiencies in hematopoietic progenitor or stem cells
05/23/2000CA2066997C Antimicrobial peptide and antimicrobial agent
05/23/2000CA2006818C Insulin derivatives, a process for the preparation thereof, the use thereof and a pharmaceutical formulation containing them
05/23/2000CA1340998C Dnas and processes for their preparation, novel plasmids possessing them, novel polypeptides and processes for their preparation and novel anti-tumor agents comprising said polypeptides
05/18/2000WO2000028323A1 Methods for identifying modulators of bs69 activity
05/18/2000WO2000028083A1 Mouse 7-transmembrane receptor gpr43
05/18/2000WO2000028062A1 Novel system for regulating transgene expression
05/18/2000WO2000028059A1 Adenovirus-mediated gene therapy
05/18/2000WO2000028047A1 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use
05/18/2000WO2000028046A1 Coffea arabica mannanase
05/18/2000WO2000028045A2 Human hydrolase proteins
05/18/2000WO2000028042A1 Use of an inducible gene for the enzyme cyclooxygenase to lower intraocular pressure
05/18/2000WO2000028041A1 Delivery of superoxide dismutase to neuronal cells
05/18/2000WO2000028040A2 Cloning of rhadinovirus genome and methods for its use
05/18/2000WO2000028039A2 Identification of senv genotypes
05/18/2000WO2000028038A2 Virulence genes and proteins, and their use
05/18/2000WO2000028035A1 CHEMOKINE β-7
05/18/2000WO2000028034A2 Cytokine signal regulators
05/18/2000WO2000028033A2 Nucleic acids and polypeptides having altered expression in the t84 gut barrier model
05/18/2000WO2000028032A2 Human cell surface receptor proteins
05/18/2000WO2000028031A2 Mitogenic regulators
05/18/2000WO2000028029A2 Cell surface glycoproteins
05/18/2000WO2000028028A1 G-protein coupled receptors, homologous to ebv-induced gpcr 2 (ebi-2). methods to seek for ligands thereof
05/18/2000WO2000028027A2 Corticosteroid synthesis-associated genes
05/18/2000WO2000028026A2 Gene expression modulated by opiate administration and withdrawal
05/18/2000WO2000028024A1 htfIIIA HUMAN GENE AND CODED hTFIIIA PROTEIN
05/18/2000WO2000028023A2 Ischaemia/reperfusion-inducible dna's and proteins
05/18/2000WO2000028021A1 A factor viii-polypeptide with factor viii:c-activity
05/18/2000WO2000028019A2 Antisense oligomer
05/18/2000WO2000028013A2 Gene expression modulated by activation of microglia or macrophages
05/18/2000WO2000028010A2 The genetic determination of genes and its use for the prophylaxis and therapy of diseases
05/18/2000WO2000028004A1 Virus vectors and methods of making and administering the same
05/18/2000WO2000028003A1 Avipox vector coding an hiv antigen and a cytokine
05/18/2000WO2000028001A1 Modified exosomes and uses
05/18/2000WO2000027994A2 Chlamydia pneumoniae genome sequence
05/18/2000WO2000027885A1 Novel chimeric polypeptide
05/18/2000WO2000027883A2 A method of treating tumors using fas-induced apoptosis
05/18/2000WO2000027881A2 Human interleukin 10 mutant proteins
05/18/2000WO2000027880A2 Rantes-derived peptides with anti-hiv activity
05/18/2000WO2000027879A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof
05/18/2000WO2000027877A1 Novel major facilitator superfamily polypeptide, uses thereof and nucleic acids encoding same
05/18/2000WO2000027876A1 Method for the isolation of lectins and the obtained purified lectins for use as a medicament
05/18/2000WO2000027875A2 Activity dependent neurotrophic factor iii (adnf iii)
05/18/2000WO2000027874A2 Nucleic acids encoding transferrin receptor-like proteins and products related thereto
05/18/2000WO2000027873A2 Interleukin-2 binding protein from arthropods
05/18/2000WO2000027868A2 Connective tissue growth factor (ctgf) and methods of use
05/18/2000WO2000027866A1 Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
05/18/2000WO2000027865A1 CHARACTERIZATION OF NOVEL GENE cbl-SL
05/18/2000WO2000027864A1 CHROMOSOME 17p-LINKED PROSTATE CANCER SUSCEPTIBILITY GENE
05/18/2000WO2000027861A1 Novel phosphodiesterase interacting proteins
05/18/2000WO2000027858A1 Antisense oligonucleotides which inhibit telomerase's activity and their uses
05/18/2000WO2000027792A1 Novel compounds and medicinal use thereof
05/18/2000WO2000027432A1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS
05/18/2000WO2000027429A2 Vaccine against papillomatous digital dermatitis (pdd)
05/18/2000WO2000027428A1 Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-cd20 antibody
05/18/2000WO2000027427A1 trmD
05/18/2000WO2000027426A1 Method for enhancing proliferation of inner ear hair cells using ligands for her2 and/or her3 receptors
05/18/2000WO2000027425A2 Pharmaceutical preparation containing a receptor-antagonist for treating blood-clotting disorders
05/18/2000WO2000027424A2 Upregulation of endogenous prostaglandins to lower intraocular pressure
05/18/2000WO2000027423A2 Methods and compositions for treating common cold symptoms
05/18/2000WO2000027422A2 Methods and compositions for treating or preventing peripheral neuropathies
05/18/2000WO2000027421A2 LOCAL USE OF SOLUBLE TUMOR NECROSIS RECEPTOR I (sTNFRI) FOR PROPHYLAXIS AND TREATMENT OF CORNEAL TRANSPLANT REJECTION AND OTHER DISORDERS OF THE EYE
05/18/2000WO2000027420A1 Compositions and methods for treatment of cancer
05/18/2000WO2000027419A1 Method for obtaining lyophilized pharmaceutical compositions of recombinant human erythropoietin stable at room temperature
05/18/2000WO2000027418A2 A method for treating tissue damaged from ischemia
05/18/2000WO2000027417A1 Pharmaceutical compositions comprising synthetic peptide copolymers and methods for preventing and treating gvhd and hvgd
05/18/2000WO2000027416A1 Stimulation of angiogenesis via syndecan-4 cytoplasmic domain signaling pathway
05/18/2000WO2000027415A2 Inhibition of angiogenesis by peptide analogs of high molecular weight kininogen domain 5
05/18/2000WO2000027414A2 Inhibition of the formation of vascular hyperpermeability
05/18/2000WO2000027380A2 Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease
05/18/2000WO2000027377A2 Phosphinate peptide analogs for the treatment of fibrotic disorders
05/18/2000WO2000027376A2 Use of thiol compounds, oxidoreductases and/or hydrolases for the treatment of tinnitus, especially chronic tinnitus
05/18/2000WO2000027363A1 Aerosols comprising nanoparticle drugs
05/18/2000WO2000027360A1 Treatment set containing lungsurfactant compositions
05/18/2000WO2000027359A1 An inhalation system
05/18/2000WO2000027352A1 Topical compositions containing whey proteins
05/18/2000WO2000027340A2 USE OF t-RNA AND FRAGMENTS FOR INHIBITING ANGIOGENESIS AND COMPOSITIONS THEREOF
05/18/2000WO2000027207A1 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
05/18/2000WO2000027204A1 Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the n-hydroxyanilide-type
05/18/2000WO2000027198A1 Retroviral vectors encoding interferon alpha and uses thereof
05/18/2000WO2000027196A1 Use of gm-csf to inhibit development of drug resistance in hiv+ patients
05/18/2000WO2000027193A1 Method for treating a patient with neoplasia by treatment with a gonadotropin releasing hormone analog
05/18/2000WO2000010590A3 Cancer treatment
05/18/2000WO2000009734A3 Methods and compositions for use in spliceosome mediated rna trans-splicing
05/18/2000WO2000009730A3 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
05/18/2000WO2000009553A3 Antimicrobial peptides isolated from the skin of american frogs
05/18/2000WO2000009525A3 Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments
05/18/2000WO2000008141A3 Short oligonucleotides for the inhibition of vegf expression
05/18/2000WO2000008140A3 Antisense oligonucleotides for the inhibition of vegf expression
1 ... 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 2409 2410 2411 ... 3163